van der Eijk AA - Search Results

1

Seroprevalence of Hepatitis E Virus in Autoimmune Hepatitis Patients in the Netherlands.

van Gerven NM, van der Eijk AA, Pas SD, Zaaijer HL, de Boer YS, Witte BI, van Nieuwkerk CM, Mulder CJ, Bouma G, de Man RA; Dutch Autoimmune Hepatitis Study Group. van Gerven NM, et al. Among authors: van der eijk aa, van nieuwkerk cm. J Gastrointestin Liver Dis. 2016 Mar;25(1):9-13. doi: 10.15403/jgld.2014.1121.251.hpe. J Gastrointestin Liver Dis. 2016. PMID: 27014749 Free article.

2

Persistence of YMDD variants after withdrawal of Lamivudine.

van der Eijk AA, Niesters HG, Pas SD, de Man RA. van der Eijk AA, et al. J Hepatol. 2002 Feb;36(2):304-5. doi: 10.1016/s0168-8278(01)00250-1. J Hepatol. 2002. PMID: 11830347 No abstract available.

3

[Lamivudine for the prevention of chronic hepatitis B exacerbations during chemotherapy for non-Hodgkin's lymphoma].

van der Eijk AA, Doorduijn JK, Janssen HL, Schalm SW, Niesters HG, de Man RA. van der Eijk AA, et al. Ned Tijdschr Geneeskd. 2002 Jun 15;146(24):1140-4. Ned Tijdschr Geneeskd. 2002. PMID: 12092307 Dutch.

4

Paired measurements of quantitative hepatitis B virus DNA in saliva and serum of chronic hepatitis B patients: implications for saliva as infectious agent.

van der Eijk AA, Niesters HG, Götz HM, Janssen HL, Schalm SW, Osterhaus AD, de Man RA. van der Eijk AA, et al. J Clin Virol. 2004 Feb;29(2):92-4. doi: 10.1016/s1386-6532(03)00092-1. J Clin Virol. 2004. PMID: 14747026

5

Quantification of the newly detected lamivudine resistant YSDD variants of Hepatitis B virus using molecular beacons.

Pas SD, Noppornpanth S, van der Eijk AA, de Man RA, Niesters HG. Pas SD, et al. Among authors: van der eijk aa. J Clin Virol. 2005 Feb;32(2):166-72. doi: 10.1016/j.jcv.2004.10.007. J Clin Virol. 2005. PMID: 15653421

6

Doctor-to-patient transmission of hepatitis B virus: the potential of antiviral therapy for prevention.

Buster EH, van der Eijk AA, de Man RA, Schalm SW. Buster EH, et al. Among authors: van der eijk aa. Scand J Gastroenterol Suppl. 2004;(241):45-9. doi: 10.1080/00855920410010997. Scand J Gastroenterol Suppl. 2004. PMID: 15696849 Review.

7

Viral dynamics during tenofovir therapy in patients infected with lamivudine-resistant hepatitis B virus mutants.

van der Eijk AA, Hansen BE, Niesters HG, Janssen HL, van de Ende M, Schalm SW, de Man RA. van der Eijk AA, et al. Among authors: van de ende m. J Viral Hepat. 2005 Jul;12(4):364-72. doi: 10.1111/j.1365-2893.2005.00620.x. J Viral Hepat. 2005. PMID: 15985006 Clinical Trial.

8

Paired, quantitative measurements of hepatitis B virus DNA in saliva, urine and serum of chronic hepatitis B patients.

van der Eijk AA, Niesters HG, Hansen BE, Pas SD, Richardus JH, Mostert M, Janssen HL, Schalm SW, de Man RA. van der Eijk AA, et al. Eur J Gastroenterol Hepatol. 2005 Nov;17(11):1173-9. doi: 10.1097/00042737-200511000-00004. Eur J Gastroenterol Hepatol. 2005. PMID: 16215428

9

Hepatitis B virus (HBV) DNA levels and the management of HBV-infected health care workers.

van der Eijk AA, de Man RA, Niesters HG, Schalm SW, Zaaijer HL. van der Eijk AA, et al. J Viral Hepat. 2006 Jan;13(1):2-4. doi: 10.1111/j.1365-2893.2005.00644.x. J Viral Hepat. 2006. PMID: 16364075 Review.

10

Wild type and YMDD variant of hepatitis B virus: no difference in viral kinetics on lamivudine/tenofovir therapy in HIV-HBV co-infected patients.

de Vries-Sluijs TE, van der Eijk AA, Hansen BE, Osterhaus AD, de Man RA, van der Ende ME. de Vries-Sluijs TE, et al. Among authors: van der ende me, van der eijk aa. J Clin Virol. 2006 May;36(1):60-3. doi: 10.1016/j.jcv.2005.12.004. Epub 2006 Jan 18. J Clin Virol. 2006. PMID: 16418013

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters